Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Smoking may affect cardiovascular disease risk more strongly in human immunodeficiency virus (HIV)-infected individuals than HIV-uninfected individuals. We hypothesized that an interaction at the level of the immune system may contribute to this increased risk. We assessed soluble markers of inflammation (high-sensitivity C-reactive protein [hsCRP]), immune activation (soluble [s]CD14 and sCD163), and coagulation (D-dimer) in HIV-infected and uninfected never, former, and current smokers. Smoking was independently associated with higher hsCRP levels and lower sCD163 levels and was borderline significantly associated with higher sCD14 and D-dimer levels. We found no evidence of a differential effect of smoking in HIV-infected individuals as compared to uninfected individuals.

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw459DOI Listing

Publication Analysis

Top Keywords

hiv-infected individuals
12
compared uninfected
8
uninfected individuals
8
associated higher
8
individuals
6
cigarette smoking
4
smoking inflammation
4
inflammation monocyte
4
monocyte activation
4
activation coagulation
4

Similar Publications

Osteoporosis is a common metabolic bone disease characterized by decreased bone density and increased fracture risk. Human immunodeficiency virus (HIV) infection is considered one of the independent risk factors for osteoporosis, but its specific mechanisms are not yet clear. This study aims to explore the relationship between HIV infection and osteoporosis based on the National Health and Nutrition Examination Survey database and to analyze the impact of related clinical factors on bone density.

View Article and Find Full Text PDF

Background: The intestinal microbiota composition has been linked to neurocognitive impairment in people with HIV (PWH). However, the potential interplay of microbial species and related metabolites, particularly in the context of an HIV cure strategy remains underexplored. The BCN02 trial evaluated the impact of romidepsin (RMD), used as a HIV-1 latency reversing agent and with reported beneficial neurological effects, combined with the MVA.

View Article and Find Full Text PDF

[Current status and challenges of AIDS-related malignant lymphoma].

Rinsho Ketsueki

September 2025

Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University.

AIDS-related malignant lymphomas (ARL) are lymphomas that develop in association with HIV infection. Although the introduction of combination antiretroviral therapy (cART) has markedly improved the life expectancy of people living with HIV (PLWH), approximately one-third of PLWH, including some with well controlled disease, still die from HIV-associated malignancies. HIV itself is not tumorigenic, and most of these tumors are due to co-infection with oncogenic viruses.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) diagnosis remains a challenge, particularly in low-resource settings. Point-of-care ultrasound (POCUS) has shown promise, but most studies focus on HIV-infected populations. In the case of TB, data on lung ultrasound (LUS) are sparse.

View Article and Find Full Text PDF

Regulatory T cells (Tregs) are pivotal in maintaining immune homeostasis by suppressing excessive immune responses, thereby preventing immunopathology. In the context of infant human immunodeficiency virus (HIV) infection, Tregs exhibit a dualistic role: while they mitigate immune activation, they may also impede effective antiviral immunity, facilitating viral persistence. Recent studies have illuminated the nuanced involvement of Tregs in infant HIV pathogenesis.

View Article and Find Full Text PDF